Trials / Active Not Recruiting
Active Not RecruitingNCT05334719
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
A Non-interventional Observational Study of Effectiveness and Safety of Nivolumab Plus Chemotherapy for Untreated Advanced / Recurrent Gastric Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness, safety, and actual treatment status of first-line nivolumab plus chemotherapy in participants with untreated advanced / recurrent gastric cancer in a Japanese real-world setting.
Detailed description
The Time Perspective for this observational study is defined as 'Retrospective and Prospective'.
Conditions
Timeline
- Start date
- 2022-06-29
- Primary completion
- 2026-01-16
- Completion
- 2026-09-30
- First posted
- 2022-04-19
- Last updated
- 2025-06-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05334719. Inclusion in this directory is not an endorsement.